Source: Journal of Cancer Therapy. Unidades: FFCLRP, FMRP
Subjects: OSTEOSSARCOMA, NEOPLASIAS ÓSSEAS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTALDI, Ana Paula et al. Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments. Journal of Cancer Therapy, v. 5, n. 4, p. 307-314, 2014Tradução . . Disponível em: https://doi.org/10.4236/jct.2014.54037. Acesso em: 02 nov. 2024.APA
Montaldi, A. P., Pezuk, J. A., Sakamoto-Hojo, E. T., Tone, L. G., & Brassesco, M. S. (2014). Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments. Journal of Cancer Therapy, 5( 4), 307-314. doi:10.4236/jct.2014.54037NLM
Montaldi AP, Pezuk JA, Sakamoto-Hojo ET, Tone LG, Brassesco MS. Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments [Internet]. Journal of Cancer Therapy. 2014 ; 5( 4): 307-314.[citado 2024 nov. 02 ] Available from: https://doi.org/10.4236/jct.2014.54037Vancouver
Montaldi AP, Pezuk JA, Sakamoto-Hojo ET, Tone LG, Brassesco MS. Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments [Internet]. Journal of Cancer Therapy. 2014 ; 5( 4): 307-314.[citado 2024 nov. 02 ] Available from: https://doi.org/10.4236/jct.2014.54037
